Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Nov 1;34(11):912–915. doi: 10.1089/aid.2018.0042

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Richard E. Haaland et al. 2018; Published by Mary Ann Liebert, Inc.

This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

FIG. 1. — Maternal and cord plasma concentrations of zidovudine (AZT), lamivudine (3TC), and nevirapine (NVP) following intermittent preventive treatment with MQ or placebo for malaria control. Zidovudine (AZT) (A), lamivudine (3TC), (B) and nevirapine (NVP) (C) concentrations are presented from maternal plasma (76 placebo study arm, 94 MQ study arm) and cord plasma (74 placebo study arm, 88 MQ study arm) specimens with detectable antiretroviral drug concentrations collected at delivery from HIV-infected pregnant women and their infants. AZT maternal plasma n = 9 (Control), 10 (MQ); cord plasma n = 26 (Control), 28 (MQ); 3TC maternal plasma n = 37 (Control), 39 (MQ); cord plasma n = 23 (Control), 31 (MQ); NVP maternal plasma n = 31 (Control), 34 (MQ); cord plasma n = 30 (Control), and 35 (MQ). MQ, mefloquine.